Concepedia

Author

Andrea Francesconi

National Cancer Institute

Also Known As

A FRANCESCONI, A Francesconi, A. Francesconi, Andrea Francesconi, Francesconi, Andrea, Orsi, Luciano

70

Publications

2.8K

Citations

26

H-Index

83

Concepts

All Affiliations

National Cancer InstituteNational Institutes of HealthOffice of Research ServicesScience Applications International Corporation (United States)National Institutes of Health Clinical Center
AF

About

Andrea Francesconi is an author at National Cancer Institute specializing in medicine, microbiology, and molecular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

3

3

293

2

Business

1

1

40

3

Education

1

1

40

4

Health Sciences

1

1

32

5

Management

1

1

40

Andrea Francesconi

×

30

Publications

2.8K

Citations

26

H-Index

YearCitations

Fusariosis Associated with Pathogenic <i>Fusarium</i> Species Colonization of a Hospital Water System: A New Paradigm for the Epidemiology of Opportunistic Mold Infections

Elias Anaissie, Robert T. Kuchar, John Rex,

Clinical Infectious Diseases

2001

318

Pathogenic Aspergillus Species Recovered from a Hospital Water System: A 3-Year Prospective Study

Elias Anaissie, Shawna L. Stratton, María Cecilia Dignani,

Clinical Infectious Diseases

2002

235

Genetic Diversity of Human Pathogenic Members of the <i>Fusarium oxysporum</i> Complex Inferred from Multilocus DNA Sequence Data and Amplified Fragment Length Polymorphism Analyses: Evidence for the Recent Dispersion of a Geographically Widespread Clonal Lineage and Nosocomial Origin

Kerry O’Donnell, Deanna A. Sutton, Michael G. Rinaldi,

Journal of Clinical Microbiology

2004

233

Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection

Peter Francis, J W Lee, A. Hoffman,

The Journal of Infectious Diseases

1994

184

Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia

Rūta Petraitienė, Vidmantas Petraitis, Andreas H. Groll,

Antimicrobial Agents and Chemotherapy

2002

181

Rapid Extraction of Genomic DNA from Medically Important Yeasts and Filamentous Fungi by High-Speed Cell Disruption

Frank‐Michael C. Müller, Katherine E. Werner, Miki Kasai,

Journal of Clinical Microbiology

1998

154

PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi

T. J. Walsh, Andrea Francesconi, Miki Kasai,

Journal of Clinical Microbiology

1995

146

Detection of a Molecular Biomarker for Zygomycetes by Quantitative PCR Assays of Plasma, Bronchoalveolar Lavage, and Lung Tissue in a Rabbit Model of Experimental Pulmonary Zygomycosis

Miki Kasai, Susan M. Harrington, Andrea Francesconi,

Journal of Clinical Microbiology

2008

134

Pathogenesis of <i>Aspergillus fumigatus</i> and the Kinetics of Galactomannan in an In Vitro Model of Early Invasive Pulmonary Aspergillosis: Implications for Antifungal Therapy

William Hope, Michael J. Kruhlak, Caron A. Lyman,

The Journal of Infectious Diseases

2007

128

Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose- Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis

Vidmantas Petraitis, Rūta Petraitienė, William Hope,

Antimicrobial Agents and Chemotherapy

2009

94

Page 1